Co-Authors
This is a "connection" page, showing publications co-authored by Markus Hoffmann and Hannah Kleine-Weber.
Connection Strength
3.093
-
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus. Emerg Microbes Infect. 2020; 9(1):155-168.
Score: 0.863
-
Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization. J Virol. 2019 01 15; 93(2).
Score: 0.803
-
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization. Cell Rep. 2021 04 20; 35(3):109017.
Score: 0.234
-
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020 09; 585(7826):588-590.
Score: 0.223
-
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 05 21; 64(6).
Score: 0.221
-
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol Cell. 2020 05 21; 78(4):779-784.e5.
Score: 0.220
-
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 04 16; 181(2):271-280.e8.
Score: 0.218
-
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Sci Rep. 2018 11 09; 8(1):16597.
Score: 0.199
-
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods. Cell Mol Immunol. 2021 04; 18(4):936-944.
Score: 0.057
-
LY6E impairs coronavirus fusion and confers immune control of viral disease. Nat Microbiol. 2020 11; 5(11):1330-1339.
Score: 0.056